Literature DB >> 7626964

Memory functions in geriatric chronic schizophrenic patients: a neuropsychological study.

P D Harvey1, P Powchik, R C Mohs, M Davidson.   

Abstract

This study characterized memory functions in geriatric schizophrenic inpatients with a battery of memory tests sensitive to neuropsychological impairments in either temporal or frontal brain regions. In patients clinically rated as cognitively impaired (n = 24), nearly all of these measures showed deficits relative to less impaired patients (n = 25). Factor analysis found consistent correlations between the tests and their putative cortical localization. Discriminant analysis suggested the pattern of impairments was not consistent with a generalized deficit. These results introduce the possibility, to be directly tested with neuropathological study, that the severe cognitive deficits in elderly schizophrenic patients are due to dysfunctions in either the temporal or frontal regions of the cerebral cortex, with the specific type of dysfunction varying across cases.

Entities:  

Mesh:

Year:  1995        PMID: 7626964     DOI: 10.1176/jnp.7.2.207

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  2 in total

1.  Visuospatial working memory in children and adolescents with 22q11.2 deletion syndrome; an fMRI study.

Authors:  Rayna Azuma; Eileen M Daly; Linda E Campbell; Angela F Stevens; Quinton Deeley; Vincent Giampietro; Michael J Brammer; Beate Glaser; Fiona Z Ambery; Robin G Morris; Steven C R Williams; Michael J Owen; Declan G M Murphy; Kieran C Murphy
Journal:  J Neurodev Disord       Date:  2009-03-05       Impact factor: 4.025

2.  RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.

Authors:  Jagadeesh Sridhara Rao; Hyung-Wook Kim; Gaylia Jean Harry; Stanley Isaac Rapoport; Edmund Arthur Reese
Journal:  Schizophr Res       Date:  2013-04-06       Impact factor: 4.939

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.